Fagedenic ulcer as appearance of cutaneous disseminate tuberculosis
Main Article Content
Keywords
Practice guidelines, Cronic obstructive pulmonary disease,
Abstract
The World Health Organization (WHO) in 2000 considered that 274 million people died in the world because of chronic obstructive pulmonary disease (COPD). Global mortality by COPD depends on the stage of the disease and 30 to 48 % die during the next four to seven years after the diagnosis. The global burden of disease for the 2020 measurement through the years of potential life lost (YPLL) estimates that COPD is in the 10th place at world-wide level. The great variability in the care of the patients with COPD, as well as the increase in the number of patients with acute exacerbations makes necessary the development of a clinical practice guideline to standardize the treatment and the interventions of rehabilitation, nutrition in the three levels of health care with the objective to improve the quality of care and to promote the efficient use of the resources.
References
Sehgal VN, Wagh SA. The history of cutaneous tuberculosis. Int J Dermatol 1990;29(9):666-668.
Baril L, Caumes E, Truffot-Pernot C, Bricaire F, Grosset J, Gentilini M. Tuberculosis caused by Mycobacterium africanum associated with involvement of the upper and lower respiratory tract, skin, and mucosa. Clin Infect Dis 1995;21(3):653-655.
Barbagallo J, Tager P, Ingleton R, Hirsch RJ, Weimberg JM. Cutaneous tuberculosis: diagnosis and treatment. Am J Clin Dermatol 2002;3(5):319-328.
Tappeiner G. Tuberculosis and infections with atypical mycobacteria. En: Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, editores. Fitzpatrick’s dermatology in general medicine. Seventh edition. USA: McGraw-Hill; 2008. p.1768-1781.
Saúl-Cano A. Dermatosis bacterianas. En: Lecciones de dermatología. Décima quinta edición. México: Méndez Editores; 2008. p. 81-210.
Hamada M, Urabe K, Moroi Y, Miyazaki M, Furue M. Epidemiology of cutaneous tuberculosis in Japan: a retrospective study from 1906 to 2002. Int J Dermatol 2004;43(10):727-731.
Garfein RS, Lozada R, Liu L, Laniado-Laborin R, Rodwell TC, Deiss R, et al. High prevalence of latent tuberculosis infection among injection drug users in Tijuana, Mexico. Int J Tuberc Lung Dis 2009;13(5):626-632.
Peto HM, Pratt RH, Harrington TA, LoBlue PA, Armstrong LR. Epidemiology of extrapulmonary tuberculosis in the United States, 1993-2006. Clin Infect Dis 2009;49(9): 1350-1357.
Vidal D, Barnadas M, Pérez M, Coll P, Alomar A. Tuber-culous gumma following venipuncture. Br J Dermatol 2001; 144(3):601-603.
Honig E, van der Meijden WI, Groeninx van Zoelen EC, De Waard-van der Spek FB. Perianal ulceration: a rare manifestation of tuberculosis. Br J Dermatol 2000;142 (1)186-187.
Velasco-Pastor M, Vilata-Corell JJ. Tuberculosis cutánea. Piel 1999;14:397-407.
Zazueta-Beltrn, J, León-Sicairos C, Canizalez-Román A. Drug resistant Mycobacterium tuberculosis un Mexico. J Infect Dev Countries 2009;3(3):162-168.
Ramam M, Mittal R, Ramesh V. How soon does cutaneous tuberculosis respond to treatment? Implications for a therapeutic test of diagnosis. Int J Dermatol 2005;44(2):121-124.
Hoon TS, Huan TB, Leok GC, Chong TK, Fong TM, Cheng TW. Detection of Mycobacterium tuberculosis DNA using polymerase chain reaction in cutaneous tuberculosis and tuberculides. Int J Dermatol 1999;38(2):122-127.
Hillemann D, Galle J, Vollmer E, Richter E. Real-time PCR assay for improved detection of Mycobacterium tuberculosis complex in paraffin-embedded tissues. Int J Tuberc Lung Dis 2006;10(3):340-342.